Cargando…
Lanreotide Depot: An Antineoplastic Treatment of Carcinoid or Neuroendocrine Tumors
PURPOSE: Peptide drugs for antineoplastic therapies usually have low oral bioavailability and short in vivo half-lives, requiring less preferred delivery methods. Lanreotide depot is a sustained-release somatostatin analog (SSA) formulation produced via an innovative peptide self-assembly method. La...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138269/ https://www.ncbi.nlm.nih.gov/pubmed/27619395 http://dx.doi.org/10.1007/s12029-016-9866-9 |